Biological optimization for mediastinal lymphoma radiotherapy – a preliminary study
<br><strong>Purpose: </strong>In current radiotherapy (RT) planning and delivery, population-based dose-volume constraints are used to limit the risk of toxicity from incidental irradiation of organs at risks (OARs). However, weighing tradeoffs between target coverage and doses to...
Auteur principal: | Aznar, M |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Taylor & Francis
2020
|
Documents similaires
-
On the Importance of Individualized, Non-Coplanar Beam Configurations in Mediastinal Lymphoma Radiotherapy, Optimized With Automated Planning
par: Linda Rossi, et autres
Publié: (2021-04-01) -
Advanced Radiotherapy Techniques for Mediastinal Lymphomas: Results from an Italian Survey
par: Anna Di Russo, et autres
Publié: (2021-08-01) -
Nivolumab combined with brentuximab vedotin with or without mediastinal radiotherapy for relapsed/refractory primary mediastinal large B-cell lymphoma
par: Loic Renaud, et autres
Publié: (2024-05-01) -
Radiotherapy after immunochemotherapy improves outcomes in patients with primary mediastinal large B‐cell lymphoma
par: Agustin Avilés, et autres
Publié: (2019-12-01) -
Linfoma mediastinal en una lactante Mediastinal lymphoma in an infant
par: Delfín Chaveco Bautista, et autres
Publié: (2010-01-01)